Product Certification&
Enterprise Certification
Country: China (Mainland)
Business Type:Lab/Research institutions
Tel: +86-173-20513646
Mobile:
Tel: +86-173-20513646
Fax:
Province/state: Hu Bei
City: Wuhan
Street: Company address: Room 005, 15th Floor, Building D2, Phase III, Software New Town, No. 8 Huacheng Avenue, East Lake High-tech Development Zone, Wuhan, Hubei Province, China
MaxCard:
CAS NO.26838-86-8
1(10--1)Metric Ton
We supply over 20000 types of spot impurity reference materials, with sufficient supply and same day delivery to meet customers' urgent needs for replenishment at any time. The company has its own research and development center and laboratory, and the team members have over ten years of experience in developing drug impurity reference standards. Our website www.molcoo.com covers over 98% of cutting-edge generic drug projects, with complete structural formulas that greatly save customers time in impurity structure analysis and inference. All products undergo strict quality control testing and provide relevant information such as COA, H-NMR, C-NMR, MS/GC-MS, HPLC/GC purity, QNMR quantification, TGA thermogravimetric analysis, IR infrared, UV ultraviolet, two-dimensional (COSY, NOESY, HMBC, HMQC), etc. These structural confirmation spectra ensure quality and reliability. Our products have a wide range of categories, fast delivery time, good quality, and low prices, which can quickly solve various customer needs such as replenishment and consistency evaluation.
Detailed Purpose Description:
Pharmaceutical Research and Development: In the drug development stage, Bisacodyl Impurity Reference Standards are used to assess the impurity content in new drugs, ensuring their safety and effectiveness. By conducting quantitative analysis of Bisacodyl impurities, researchers can optimize production processes, reduce impurity generation, and improve drug quality.
Quality Control: During drug production, Bisacodyl Impurity Reference Standards serve as a key tool for quality control, used to detect whether the impurity content in finished drugs meets specified standards. This helps ensure that each batch of produced drugs achieves the expected purity and quality.
Drug Testing: When conducting drug approval and testing, regulatory agencies use Bisacodyl Impurity Reference Standards to verify the accuracy of detection methods and results for impurities in drugs. This helps safeguard public drug safety and prevent unqualified drugs from entering the market.
Stability Studies: In drug stability studies, Bisacodyl Impurity Reference Standards are used to evaluate impurity generation in drugs under different storage conditions. This helps determine the shelf life and storage conditions of drugs, ensuring they maintain stable quality within their validity period.
Regulatory Compliance: The use of Bisacodyl Impurity Reference Standards helps pharmaceutical companies comply with relevant domestic and international drug regulations and quality standards, ensuring drugs meet market requirements.